Answers are grounded in this paper and cite their sources.
Cross-sectional analysis quantifies chemotherapy-induced nausea and vomiting studies, highlighting trends in emetogenicity over time.
Chemotherapy-induced nausea and vomiting (CINV) has been studied for decades, yet the overall scope and evolution of this literature have not been quantified. We conducted a cross-sectional survey of primary research articles on CINV published from database inception through January 2026, categorizing studies by chemotherapy emetogenicity. Nearly 3000 studies were identified, with publication output peaking in the 2010s and focusing predominantly on highly emetogenic regimens. These trends reflect historical clinical priorities and advances in antiemetic therapy.
No takes yet. Share an insight, caveat, or question.
Chow et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: